| Name | Title | Contact Details |
|---|
The Buck Institute is committed to providing a strong benefits package as part of its total compensation program.
Absolute Total Care is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pioneer Medical Group is a leader in the Hospitalist movement, providing the highest level of Hospital Medicine and Post Transition Care to Florida Hospitals in the West and Central Florida Region.
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Mount Sinai New York University Health is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about Mount Sinai New York University Health, please visit www.msnyuhealth.org